Sunshine Biopharma Inc.

NASDAQ: SBFM · Real-Time Price · USD
1.50
-0.01 (-0.66%)
At close: Aug 15, 2025, 10:09 AM

Sunshine Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
34.87M 24.09M 4.35M 228.43K
Cost of Revenue
24.2M 15.75M 2.65M 117.83K
Gross Profit
10.67M 8.34M 1.7M 110.6K
Operating Income
-5.81M -4.79M -27M -2.44M
Interest Income
496K 811.97K 518.65K n/a
Pretax Income
-5.37M -4.11M -26.51M -12.44M
Net Income
-5.13M -4.51M -26.74M -12.44M
Selling & General & Admin
14.94M 10.83M 9.48M 1.87M
Research & Development
933.9K 1.86M 811.86K 672.21K
Other Expenses
610.53K 438.88K 80.4K 12.74K
Operating Expenses
16.48M 13.12M 10.37M 2.55M
Interest Expense
8.77K 137.31K 39.41K 328.82K
Selling & Marketing Expenses
940.28K 734.25K 578.09K n/a
Cost & Expenses
40.69M 28.88M 13.02M 2.67M
Income Tax Expense
-235K 395.17K 233.3K n/a
Shares Outstanding (Basic)
701.75K 12.16K 7.59K 1.31K
Shares Outstanding (Diluted)
701.75K 12.16K 7.59K 1.31K
EPS (Basic)
-7.32 -351.36 -3.52K -9.77K
EPS (Diluted)
-7.32 -351.36 -3.52K -9.52K
EBITDA
-5.15M -3.82M -26.45M -12.1M
EBIT
-5.36M -3.97M -26.47M -12.11M
Depreciation & Amortization
223.53K 149.15K 25.16K 12.74K